Model development and comparison of low hemorrhage-risk endoluminal patch thrombolytic treatment for ischemic stroke
A thrombus blocking flow in a blood vessel deprives the brain cells of oxygen resulting in ischemic stroke and paralysis [1]. Thrombolysis treatment can be used to unblock the vessel [2]. A high dose of thrombolytic agents (urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA)) is administered to dissolve the blocking thrombus in eligible patients who are within 4.5 h from stroke onset [3,4]. Typically, 10,000–60,000 IU/kg (
Source: Medical Engineering and Physics - Category: Biomedical Engineering Authors: Zhen Qin, Francesco Ciucci, Chi Hang Chon, John C.K. Kwok, David C.C. Lam Source Type: research
More News: Biomedical Engineering | Brain | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Physics | Stroke | Thrombosis